News
Anal Cancer
Bladder Cancer
Bone Cancer
Brain Cancer
Breast Cancer
Cancer of Unknown Primary
Cervical Cancer
Colon Cancer
Esophageal Cancer
Gastric Cancer
GIST
Head & Neck Cancer
Hodgkins Lymphoma
Leukemia
Acute Leukemia
Chronic Lymphocytic Leukemia
Chronic Myeloid Leukemia
Liver Cancer
Lung Cancer
Melanoma
Mesothelioma
Multiple Myeloma
Myelodysplastic Syndrome
MPN-PV-ET-MF
Neuroblastoma
Neuroendocrine Tumors
Non Hodgkins Lymphoma
Ovarian Cancer
Pancreatic Cancer
Prostate Cancer
Renal Cancer
Rectal Cancer
Sarcoma
Skin Care
Skin Cancer
Testicular Cancer
Thyroid Cancer
Triple Negative Breast Cancer
Uterine Cancer
About Us
Advertising
News
Newly Diagnosed
Treatment & Care
Survivorship
Join the Community
Newsletter
Search
Tecentriq (atezolizumab)
April 11, 2024
Checkpoint Inhibitor – Chemotherapy for Treatment of Small Cell Lung Cancer
Charles H. Weaver, MD
October 27, 2023
Perioperative and Neoadjuvant Immunotherapy in Early Stage Lung Cancer
Charles H. Weaver, MD
October 24, 2023
Keytruda & Other Checkpoint Inhibitors for Triple Negative Breast Cancer
Charles H. Weaver, MD
September 23, 2023
TIGIT Inhibitor May Improve Treatment of Liver Cancer
Charles H. Weaver, MD
January 25, 2023
Tecentriq-Avastin for Early Stage Liver Cancer
Charles H. Weaver, MD
December 13, 2022
FDA Approves Tecentriq for Alveolar Soft Part Sarcoma
Charles H. Weaver, MD
April 13, 2021
Treatment of Stage I – III Non-Small Cell Lung Cancer
Charles H. Weaver, MD
December 30, 2019
Checkpoint Inhibitors + Avastin for Recurrent Ovarian Cancer
Charles H. Weaver, MD
October 10, 2019
Tecentriq Immunotherapy Provides Benefit in Advanced Bladder Cancer
Charles H. Weaver, MD
July 25, 2019
Lenvima for Treatment of Advanced Liver Cancer
Charles H. Weaver, MD
August 7, 2018
Abraxane for Triple-Negative Breast Cancer
Charles H. Weaver, MD
Loading Comments...
Write a Comment...
Email (Required)
Name (Required)
Website
